Xemda Pharmaceuticals Private Limited
About Xemda Pharmaceuticals Private Limited
Data last updated:
Xemda Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 06 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24111DL2018PTC342656. Its GSTIN is 10AAACX2780R1Z0 (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Sanjay Kumar (Managing Director) and Nirmala Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H/O Md. Ansar Hussain U – 128 Upper G/F Kh No.343&344 U – Block Subash Park Back Side, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹28.89 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net loss of ₹35,565 (net margin -1.2%) and EBITDA of ₹6,456 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 6% over five years.
Company details
Contact details
Xemda Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressH/O Md. Ansar Hussain U – 128 Upper G/F Kh No.343&344 U – Block Subash Park Back Side, New Delhi, Delhi, India – 110059
- IndustryChemicals, Manufacturing, Basic Chemical, Basic Chemicals Except Fertilizers And Nitrogen Compounds
To see the full contact details of Xemda Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Xemda Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Xemda Pharmaceuticals Private Limited, buy the company report.
Financials of Xemda Pharmaceuticals Private Limited
FY 2025 filings availableXemda Pharmaceuticals Private Limited reported revenue of ₹28.89 Lakh (down 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 94% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6,456 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹35,565 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | -1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xemda Pharmaceuticals Private Limited, buy the company report.
Board of directors of Xemda Pharmaceuticals Private Limited
Xemda Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirmala Kumari | Director | 06 Dec 2018 | 7 Years 10 Months | Current |
| Sanjay Kumar Also directs: Admex Biogenics Private Limited | Managing Director | 06 Dec 2018 | 7 Years 10 Months | Current |
Peer comparison
Xemda Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Xemda Pharmaceuticals Private Limitedthis company | ₹28.89 Lakh (FY 2025) | -₹35,565 | -1.2% | -10.0% | New Delhi, Delhi, India | |
| Melden Pharmaceuticals Private Limited | ₹28.86 Lakh (FY 2017) | Bangalore, Karnataka, India | ||||
| SBJ Pharmaceuticals Private Limited | ₹28.83 Lakh (FY 2024) | Delhi, India | ||||
| Novotel Pharmaceuticals Private Limited | ₹28.82 Lakh (FY 2025) | 216.0% | Patna, Bihar, India |
To see the full peer comparison of Xemda Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Xemda Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xemda Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xemda Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAACX2780R1Z0 | Bihar | Active | 19 Feb 2019 |
To see the full GST registrations and return filing status of Xemda Pharmaceuticals Private Limited, buy the company report.
Recent activity
Xemda Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Nirmala Kumari was appointed as Director on 06 Dec 2018.
Frequently asked questions
Xemda Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 06 December 2018 (8+ years old) and is registered under CIN U24111DL2018PTC342656.
Xemda Pharmaceuticals has 2 current directors:
- Sanjay Kumar - Managing Director
- Nirmala Kumari - Director
The latest financial statements of Xemda Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Xemda Pharmaceuticals is 10AAACX2780R1Z0, registered in Bihar.
The CIN (Corporate Identification Number) of Xemda Pharmaceuticals is U24111DL2018PTC342656. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xemda Pharmaceuticals was incorporated on 06 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Xemda Pharmaceuticals by revenue are Melden Pharmaceuticals Private Limited, SBJ Pharmaceuticals Private Limited, Novotel Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading).
Nirmala Kumari was appointed as Director on 06 Dec 2018. Sanjay Kumar was appointed as Managing Director on 06 Dec 2018.
The registered office of Xemda Pharmaceuticals is at HO Md. Ansar Hussain U – 128 Upper GF Kh No.343&344 U – Block Subash Park Back Side, New Delhi, Delhi, India – 110059.
Xemda Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Xemda Pharmaceuticals can be reached at its registered office: HO Md. Ansar Hussain U – 128 Upper GF Kh No.343&344 U – Block Subash Park Back Side, New Delhi, Delhi, India – 110059.